Literature DB >> 28861161

miR-320 inhibited ovarian cancer oncogenicity via targeting TWIST1 expression.

Chunyang Li1, Ping Duan2, Jianguang Wang1, Xiaosheng Lu3, Jing Cheng3.   

Abstract

Ovarian cancer is the most lethal gynecological cancer in most countries. Increasing studies have demonstrated that dysregulation of microRNAs (miRNAs) can contribute to cancer progression. In this study, we showed that miR-320 was underexpressed in ovarian cancer samples compared to their non-tumor tissues. The expression of Twist homolog 1 (TWIST1) in ovarian cancer tissues was upregulated compared with that in the non-tumorous tissues. We found that the expression of TWIST1 was inversely correlated with that of miR-320 in the ovarian cancer. Overexpression of miR-320 suppressed cell proliferation, cell cycle and invasion in ovarian cancer. We identified TWIST1 as a direct target gene of miR-320 in the ovarian cancer cell. Overexpression of TWIST1 promoted the ovarian cancer cell proliferation, cell cycle and invasion. Ectopic expression of TWIST1 restored the effects of miR-320 on cell proliferation, cell cycle and invasion. These findings revealed that miR-320 was a tumor suppressive gene that supressed cell prloferation, cycle and invasion through targeting TWIST1 in ovarian cancer.

Entities:  

Keywords:  Ovarian cancer; TWIST1; miR-320; microRNAs

Year:  2017        PMID: 28861161      PMCID: PMC5575184     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  50 in total

1.  PAQR3 enhances Twist1 degradation to suppress epithelial-mesenchymal transition and metastasis of gastric cancer cells.

Authors:  Weiwei Guo; Xue You; Daqian Xu; Yuxue Zhang; Zheng Wang; Kaiyang Man; Zhenzhen Wang; Yan Chen
Journal:  Carcinogenesis       Date:  2016-02-10       Impact factor: 4.944

2.  AKT1 Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer through Phosphorylation-Dependent Twist1 Degradation.

Authors:  Chia-Wei Li; Weiya Xia; Seung-Oe Lim; Jennifer L Hsu; Longfei Huo; Yun Wu; Long-Yuan Li; Chien-Chen Lai; Shih-Shin Chang; Yi-Hsin Hsu; Hui-Lung Sun; Jongchan Kim; Hirohito Yamaguchi; Dung-Fang Lee; Hongmei Wang; Yan Wang; Chao-Kai Chou; Jung-Mao Hsu; Yun-Ju Lai; Adam M LaBaff; Qingqing Ding; How-Wen Ko; Fuu-Jen Tsai; Chang-Hai Tsai; Gabriel N Hortobagyi; Mien-Chie Hung
Journal:  Cancer Res       Date:  2016-01-12       Impact factor: 12.701

3.  Exosome-derived miRNAs and ovarian carcinoma progression.

Authors:  Olga Vaksman; Claes Tropé; Ben Davidson; Reuven Reich
Journal:  Carcinogenesis       Date:  2014-06-12       Impact factor: 4.944

Review 4.  MicroRNA dysregulation in rhabdomyosarcoma: a new player enters the game.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Yang Liu; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2015-07-23       Impact factor: 6.831

5.  The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.

Authors:  Mariyam Zuberi; Imran Khan; Gauri Gandhi; P C Ray; Alpana Saxena
Journal:  Tumour Biol       Date:  2016-03-07

Review 6.  Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer.

Authors:  Lingyun Zhang; Lubna Nadeem; Kristin Connor; Guoxiong Xu
Journal:  Curr Cancer Drug Targets       Date:  2016       Impact factor: 3.428

7.  Twist1 induces distinct cell states depending on TGFBR1-activation.

Authors:  Diana Dragoi; Anja Krattenmacher; Vivek K Mishra; Johanna M Schmidt; Uwe J Kloos; Lisa K Meixner; Stefanie M Hauck; Felix Buggenthin; Dennis Schwartz; Carsten Marr; Steven A Johnsen; Christina H Scheel
Journal:  Oncotarget       Date:  2016-05-24

8.  Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cells.

Authors:  Perla M Báez-Vega; Ileabett M Echevarría Vargas; Fatma Valiyeva; Joel Encarnación-Rosado; Adriana Roman; Josean Flores; María J Marcos-Martínez; Pablo E Vivas-Mejía
Journal:  Oncotarget       Date:  2016-06-14

9.  GNAI1 Suppresses Tumor Cell Migration and Invasion and is Post-Transcriptionally Regulated by Mir-320a/c/d in Hepatocellular Carcinoma.

Authors:  Jian Yao; Lin-Hui Liang; Yu Zhang; Jie Ding; Qi Tian; Jin-Jun Li; Xiang-Huo He
Journal:  Cancer Biol Med       Date:  2012-12       Impact factor: 4.248

10.  Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.

Authors:  Xiaodan Meng; Volkmar Müller; Karin Milde-Langosch; Fabian Trillsch; Klaus Pantel; Heidi Schwarzenbach
Journal:  Oncotarget       Date:  2016-03-29
View more
  16 in total

1.  Hypoxic Environment Promotes Barrier Formation in Human Intestinal Epithelial Cells through Regulation of MicroRNA 320a Expression.

Authors:  Megan L Stanifer; Steeve Boulant; Stephanie Muenchau; Rosalie Deutsch; Ines J de Castro; Thomas Hielscher; Nora Heber; Beate Niesler; Marina Lusic
Journal:  Mol Cell Biol       Date:  2019-06-27       Impact factor: 4.272

Review 2.  The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract.

Authors:  William Frank Ferris
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

3.  Emodin inhibits pancreatic cancer EMT and invasion by up‑regulating microRNA‑1271.

Authors:  Nan Li; Chunli Wang; Peng Zhang; Shengyi You
Journal:  Mol Med Rep       Date:  2018-07-23       Impact factor: 2.952

Review 4.  Mechanisms of Vasculogenic Mimicry in Ovarian Cancer.

Authors:  Lízbeth Ayala-Domínguez; Leslie Olmedo-Nieva; J Omar Muñoz-Bello; Adriana Contreras-Paredes; Joaquín Manzo-Merino; Imelda Martínez-Ramírez; Marcela Lizano
Journal:  Front Oncol       Date:  2019-09-27       Impact factor: 6.244

5.  Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer.

Authors:  Youyong Tang; Yajing Zhao; Xingguo Song; Xianrang Song; Limin Niu; Li Xie
Journal:  J Clin Lab Anal       Date:  2019-08-16       Impact factor: 2.352

6.  LINC00680 and TTN-AS1 Stabilized by EIF4A3 Promoted Malignant Biological Behaviors of Glioblastoma Cells.

Authors:  Wei Tang; Di Wang; Lianqi Shao; Xiaobai Liu; Jian Zheng; Yixue Xue; Xuelei Ruan; Chunqing Yang; Libo Liu; Jun Ma; Zhen Li; Yunhui Liu
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-16       Impact factor: 8.886

7.  CircHECTD1 Regulates Cell Proliferation and Migration by the miR-320-5p/SLC2A1 Axis in Glioblastoma Multiform.

Authors:  Wen Li; Shanshan Wang; Boquan Shan; Xiang Cheng; Hui He; Jianbing Qin; Yi Tang; Heyan Zhao; Meiling Tian; Xinhua Zhang; Guohua Jin
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

Review 8.  MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy.

Authors:  Yuanyuan Liang; Shun Li; Liling Tang
Journal:  Biomedicines       Date:  2021-05-23

9.  MicroRNA-320 Enhances Radiosensitivity of Glioma Through Down-Regulation of Sirtuin Type 1 by Directly Targeting Forkhead Box Protein M1.

Authors:  Tengfei Li; Ji Ma; Xinwei Han; Yongxu Jia; Huifeng Yuan; Shaofeng Shui; Dong Guo
Journal:  Transl Oncol       Date:  2018-01-11       Impact factor: 4.243

10.  Exosomal microRNAs as tumor markers in epithelial ovarian cancer.

Authors:  Chi Pan; Ines Stevic; Volkmar Müller; Qingtao Ni; Leticia Oliveira-Ferrer; Klaus Pantel; Heidi Schwarzenbach
Journal:  Mol Oncol       Date:  2018-10-09       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.